Skip to main navigation Skip to search Skip to main content

Improved treatment satisfaction and perceived metabolic control with insulin glargine, regardless of whether injected before breakfast, dinner or bedtime, in patients with Type 1 diabetes [Abstract 2925]

Research output: Contribution to journalArticlepeer-review

55 Downloads (Pure)
Original languageEnglish
Pages (from-to)Abstract 2925
JournalDiabetes & Metabolism
Volume29
Issue number4S408
Publication statusPublished - 2003

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this